Education
About Us
Working with TipRanks
Follow Us
Smith & Nephew (UK) (GB:SN)
:SN
SN Stock Chart & Stats
Day’s Range― - ―
52-Week Range911.00p - 1,245.26p
Previous CloseN/A
Volume71.06K
Average Volume (3M)2.16M
Market Cap
£10.03B
Enterprise Value10.99B
Total Cash (Recent Filing)$137.00M
Total Debt (Recent Filing)$2.13B
Price to Earnings (P/E)31.1
Beta1.04
Next Earnings
Jul 31, 2025EPS Estimate
36.62Next Dividend Ex-Date
Mar 27, 2025Dividend Yield2.57%
Share Statistics
EPS (TTM)0.37
Shares Outstanding874,410,100
10 Day Avg. Volume3,166,138
30 Day Avg. Volume2,164,491
Standard Deviation0.07
R-Squared0.27
Alpha-0.00871
Financial Highlights & Ratios
PEG Ratio0.60
Price to Book (P/B)N/A
Price to Sales (P/S)2.22
Price to Cash Flow (P/CF)26.30
P/FCF Ratio46.30
Enterprise Value/Market Cap1.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.82
Enterprise Value/Ebitda10.32
Forecast
1Y Price Target
1,248.14pPrice Target Upside8.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceManagement has achieved $210m in savings to date, with a target of $300m by the end of 2025.
Market PositionThe company holds a strong position in the European market with its robotic platform, ranking as the #1 provider.
Bears Say
Sales PerformanceOrtho sales in China were significantly down and are expected to continue at the same extent in the near term.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.10% Insiders
13.83% Mutual Funds
<0.01% Other Institutional Investors
77.24% Public Companies and Individual Investors
SN FAQ
What was Smith & Nephew (UK)’s price range in the past 12 months?
Smith & Nephew (UK) lowest share price was 911.00p and its highest was 1245.26p in the past 12 months.
What is Smith & Nephew (UK)’s market cap?
Smith & Nephew (UK)’s market cap is £10.03B.
When is Smith & Nephew (UK)’s upcoming earnings report date?
Smith & Nephew (UK)’s upcoming earnings report date is Jul 31, 2025 which is in 149 days.
How were Smith & Nephew (UK)’s earnings last quarter?
Smith & Nephew (UK) released its earnings results on Feb 25, 2025. The company reported 0.371p earnings per share for the quarter, beating the consensus estimate of 0.365p by 0.006p.
Is Smith & Nephew (UK) overvalued?
According to Wall Street analysts Smith & Nephew (UK)’s price is currently Undervalued.
Does Smith & Nephew (UK) pay dividends?
Smith & Nephew (UK) pays a Annually dividend of 29.468p which represents an annual dividend yield of 2.57%. See more information on Smith & Nephew (UK) dividends here
What is Smith & Nephew (UK)’s EPS estimate?
Smith & Nephew (UK)’s EPS estimate is 36.62.
How many shares outstanding does Smith & Nephew (UK) have?
Smith & Nephew (UK) has 874,410,100 shares outstanding.
What happened to Smith & Nephew (UK)’s price movement after its last earnings report?
Smith & Nephew (UK) reported an EPS of 0.371p in its last earnings report, beating expectations of 0.365p. Following the earnings report the stock price went up 6.133%.
Which hedge fund is a major shareholder of Smith & Nephew (UK)?
Currently, no hedge funds are holding shares in GB:SN
---
Smith & Nephew Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
1,248.14p (8.49% Upside)
1,248.14p (8.49% Upside)
Insider Transactions
Bought Shares
Worth £365.1K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
15.05%
12-Months-Change
Fundamentals
Return on Equity
7.78%
Trailing 12-Months
Asset Growth
5.53%
Trailing 12-Months
Company Description
Smith & Nephew (UK)
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
---
SN Stock 12 Month Forecast
Average Price Target
1,248.14p
▲(8.49% Upside)
Technical Analysis
Best Analysts Covering SN
1 Year
1 Year Success Rate
6/7 ratings generated profit
1 Year Average Return
+12.17%
reiterated a buy rating 7 days ago
Copying David Adlington's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +12.17% per trade.
---